In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidate

BackgroundTechnical limitations for culturing the human malaria parasite Plasmodium vivax have impaired the discovery of vaccine candidates, challenging the malaria eradication agenda. The immunogenicity of the M2 domain of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) antigen cloned from the Plasmodium yoelii murine parasite, has been previously demonstrated.ResultsDetailed epitope mapping of MAEBL through immunoinformatics identified several MHCI, MHCII and B cell epitopes throughout the peptide, with several of these lying in the M2 domain and being conserved between P. vivax, P. yoelii and Plasmodium falciparum, hinting that the M2-MAEBL is pan-reactive. This hypothesis was tested through functional assays, showing that P. yoelii M2-MAEBL antisera are able to recognize and inhibit erythrocyte invasion from both P. falciparum and P. vivax parasites isolated from Thai patients, in ex vivo assays. Moreover, the sequence of the M2-MAEBL is shown to be highly conserved between P. vivax isolates from the Amazon and Thailand, indicating that the MAEBL antigen may constitute a vaccine candidate outwitting strain-specific immunity.ConclusionsThe MAEBL antigen is promising candidate towards the development of a malaria vaccine.

[1]  Ellis L. Reinherz,et al.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles , 2004, Immunogenetics.

[2]  J. Adams,et al.  A family of chimeric erythrocyte binding proteins of malaria parasites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Reinherz,et al.  Prediction of peptide-MHC binding using profiles. , 2007, Methods in molecular biology.

[4]  J. Stevens,et al.  Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites. , 2002, Molecular biology and evolution.

[5]  Morten Nielsen,et al.  NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.

[6]  P. Blair,et al.  Antibodies against MAEBL Ligand Domains M1 and M2 Inhibit Sporozoite Development In Vitro , 2004, Infection and Immunity.

[7]  L. Rénia,et al.  Breadth of humoral response and antigenic targets of sporozoite‐inhibitory antibodies associated with sterile protection induced by controlled human malaria infection , 2016, Cellular microbiology.

[8]  Morten Nielsen,et al.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method , 2007, BMC Bioinformatics.

[9]  G. Snounou,et al.  Nested PCR analysis of Plasmodium parasites. , 2002, Methods in molecular medicine.

[10]  S. Kappe,et al.  Plasmodium falciparum MAEBL is a unique member of the ebl family. , 2002, Molecular and biochemical parasitology.

[11]  G. Wunderlich,et al.  Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection , 2015, Infection and Immunity.

[12]  J. Adams,et al.  Plasmodium yoelii YM MAEBL protein is coexpressed and colocalizes with rhoptry proteins. , 1998, Molecular and biochemical parasitology.

[13]  Ashley I Heinson,et al.  The promise of reverse vaccinology. , 2015, International health.

[14]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[15]  M. Galinski,et al.  Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3 , 2013, PloS one.

[16]  R. Newman,et al.  Malaria vaccine technology roadmap , 2013, The Lancet.

[17]  F. Corpet.  Multiple sequence alignment with hierarchical clustering. , 1988, Nucleic acids research.

[18]  P. Kloetzel,et al.  MAPPP: MHC class I antigenic peptide processing prediction. , 2003, Applied bioinformatics.

[19]  A. Chaudhuri,et al.  Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. , 2007, Experimental parasitology.

[20]  W H TALIAFERRO,et al.  Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.

[21]  C. B. Evans,et al.  Monoclonal antibodies to stage-specific, species-specific, and cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii , 1981, Infection and immunity.

[22]  Neil Hall,et al.  The genome of model malaria parasites, and comparative genomics. , 2005, Current issues in molecular biology.

[23]  J. Adams,et al.  Erythrocyte binding protein homologues of rodent malaria parasites. , 1997, Molecular and biochemical parasitology.

[24]  D. Freilich,et al.  Identification, expression, and functional characterization of MAEBL, a sporozoite and asexual blood stage chimeric erythrocyte-binding protein of Plasmodium falciparum. , 2002, Molecular and biochemical parasitology.

[25]  J. Carlton,et al.  Gene synteny in species of Plasmodium. , 1998, Molecular and biochemical parasitology.

[26]  M. Patarroyo,et al.  Functional, structural, and immunological compartmentalisation of malaria invasive proteins. , 2007, Biochemical and biophysical research communications.

[27]  E. Reinherz,et al.  Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.

[28]  Vasant G Honavar,et al.  Predicting linear B‐cell epitopes using string kernels , 2008, Journal of molecular recognition : JMR.

[29]  J. Adams,et al.  Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein , 1997, Infection and immunity.

[30]  J. Adams,et al.  Exploring the transcriptome of the malaria sporozoite stage , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Flower,et al.  Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. , 2007, Vaccine.

[32]  F. Kironde,et al.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth , 1994, Infection and immunity.

[33]  C. Newbold,et al.  Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum. , 1983, Molecular and biochemical parasitology.

[34]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[35]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[36]  Y. Chinzei,et al.  MAEBL Is Essential for Malarial Sporozoite Infection of the Mosquito Salivary Gland , 2002, The Journal of experimental medicine.

[37]  Deborah Hix,et al.  The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..

[38]  Gajendra P. S. Raghava,et al.  ProPred1: Prediction of Promiscuous MHC Class-I Binding Sites , 2003, Bioinform..

[39]  Esther G. L. Koh,et al.  A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax , 2011, Blood.

[40]  R. Cibulskis,et al.  World Malaria Report 2013 , 2014 .